Brenner AJ - Search Results

1

Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide.

Lodi A, Pandey R, Chiou J, Bhattacharya A, Huang S, Pan X, Burgman B, Yi SS, Tiziani S, Brenner AJ. Lodi A, et al. Among authors: brenner aj. Front Oncol. 2022 Sep 26;12:900082. doi: 10.3389/fonc.2022.900082. eCollection 2022. Front Oncol. 2022. PMID: 36226069 Free PMC article.

2

Metabolomic signature of brain cancer.

Pandey R, Caflisch L, Lodi A, Brenner AJ, Tiziani S. Pandey R, et al. Among authors: brenner aj. Mol Carcinog. 2017 Nov;56(11):2355-2371. doi: 10.1002/mc.22694. Epub 2017 Jul 17. Mol Carcinog. 2017. PMID: 28618012 Free PMC article. Review.

3

Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study.

Brenner A, Zuniga R, Sun JD, Floyd J, Hart CP, Kroll S, Fichtel L, Cavazos D, Caflisch L, Gruslova A, Huang S, Liu Y, Lodi A, Tiziani S. Brenner A, et al. Neuro Oncol. 2018 Aug 2;20(9):1231-1239. doi: 10.1093/neuonc/noy015. Neuro Oncol. 2018. PMID: 29415215 Free PMC article. Clinical Trial.

4

Stable Isotope Dilution LC-HRMS Assay To Determine Free SN-38, Total SN-38, and SN-38G in a Tumor Xenograft Model after Intravenous Administration of Antibody-Drug Conjugate (Sacituzumab Govitecan).

Pandey R, Gruslova A, Chiou J, Brenner AJ, Tiziani S. Pandey R, et al. Among authors: brenner aj. Anal Chem. 2020 Jan 7;92(1):1260-1267. doi: 10.1021/acs.analchem.9b04419. Epub 2019 Dec 9. Anal Chem. 2020. PMID: 31765123

5

The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.

Kosti A, de Araujo PR, Li WQ, Guardia GDA, Chiou J, Yi C, Ray D, Meliso F, Li YM, Delambre T, Qiao M, Burns SS, Lorbeer FK, Georgi F, Flosbach M, Klinnert S, Jenseit A, Lei X, Sandoval CR, Ha K, Zheng H, Pandey R, Gruslova A, Gupta YK, Brenner A, Kokovay E, Hughes TR, Morris QD, Galante PAF, Tiziani S, Penalva LOF. Kosti A, et al. Genome Biol. 2020 Aug 6;21(1):195. doi: 10.1186/s13059-020-02115-y. Genome Biol. 2020. PMID: 32762776 Free PMC article.

6

Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma.

Brenner AJ, Floyd J, Fichtel L, Michalek J, Kanakia KP, Huang S, Reardon D, Wen PY, Lee EQ. Brenner AJ, et al. Sci Rep. 2021 Jan 27;11(1):2306. doi: 10.1038/s41598-021-81841-0. Sci Rep. 2021. PMID: 33504881 Free PMC article. Clinical Trial.

7

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and ¹⁸F-FMISO PET.

Huang S, Michalek JE, Reardon DA, Wen PY, Floyd JR, Fox PT, Clarke GD, Jerabek PA, Schmainda KM, Muzi M, Hyun H, Lee EQ, Brenner AJ. Huang S, et al. Among authors: brenner aj. Sci Rep. 2021 Apr 7;11(1):7632. doi: 10.1038/s41598-021-84331-5. Sci Rep. 2021. PMID: 33828310 Free PMC article.

8

ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics.

Kosti A, Chiou J, Guardia GDA, Lei X, Balinda H, Landry T, Lu X, Qiao M, Gilbert A, Brenner A, Galante PAF, Tiziani S, Penalva LOF. Kosti A, et al. Neuro Oncol. 2023 Mar 14;25(3):459-470. doi: 10.1093/neuonc/noac179. Neuro Oncol. 2023. PMID: 35862252 Free PMC article.

9

Predicting the spatio-temporal response of recurrent glioblastoma treated with rhenium-186 labelled nanoliposomes.

Christenson C, Wu C, Hormuth DA 2nd, Huang S, Bao A, Brenner A, Yankeelov TE. Christenson C, et al. Brain Multiphys. 2023 Dec;5:100084. doi: 10.1016/j.brain.2023.100084. Epub 2023 Oct 29. Brain Multiphys. 2023. PMID: 38187909 Free PMC article.

10

Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial.

Balinda HU, Kelly WJ, Kaklamani VG, Lathrop KI, Canola MM, Ghamasaee P, Sareddy GR, Michalek J, Gilbert AR, Surapaneni P, Tiziani S, Pandey R, Chiou J, Lodi A, Floyd JR 2nd, Brenner AJ. Balinda HU, et al. Among authors: brenner aj. Nat Commun. 2024 Aug 7;15(1):6707. doi: 10.1038/s41467-024-50558-9. Nat Commun. 2024. PMID: 39112464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters